Stryker Corporation logo

Stryker Corporation (1SYK)

Market Closed
30 Sep, 03:30 PM
XMIL XMIL
€
242. 30
0
0%
€
121.11B Market Cap
43.11 P/E Ratio
0.15% Div Yield
90 Volume
10.41 Eps
€ 242.3
Previous Close
Add Transaction
Day Range
242.3 242.3
Year Range
230 345.9
Want to track 1SYK and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

1SYK closed Wednesday higher at €242.3, an increase of 0% from Tuesday's close, completing a monthly increase of 0% or €0. Over the past 12 months, 1SYK stock lost -19.2602%.
1SYK pays dividends to its shareholders, with the most recent payment made on Apr 07, 2026.
The last earnings report, released on Apr 29, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -1.4633%, based on the last three reports.
Stryker Corporation has completed 9 stock splits, with the recent split occurring on May 17, 2004.
The company's stock is traded on 10 different exchanges and in various currencies, with the primary listing on NYSE (USD).

1SYK Chart

Stryker: This Dividend Aristocrat Is Finally Cheap Again

Stryker: This Dividend Aristocrat Is Finally Cheap Again

Stryker is upgraded to 'Strong Buy' after a significant price pullback to $275, offering compelling value relative to historical valuation. SYK demonstrates robust organic sales growth, balanced across geographies and segments, with strong demand and elevated equipment backlogs. Key growth drivers include Mako robotic-assisted procedures, ASC expansion, and Smart Care platform integration, supporting double-digit EPS growth expectations.

Seekingalpha | 1 week ago
Stryker Expands Foot & Ankle Innovation With Prophecy and smartHEX

Stryker Expands Foot & Ankle Innovation With Prophecy and smartHEX

SYK expands its Foot & Ankle portfolio with Prophecy for Incompass and smartHEX, linking planning, implants and limb reconstruction.

Zacks | 4 weeks ago
Stryker: Operational Issues Have Created An Opportunity

Stryker: Operational Issues Have Created An Opportunity

Stryker's share price has declined significantly in recent months on the back of operational issues, valuation concerns, and weaker orthopedic procedure volume growth. Despite headwinds, Stryker's growth is still solid and should rebound once the Vascular manufacturing issue is resolved. Further margin expansion is also an underappreciated part of the Stryker story.

Seekingalpha | 1 month ago

Stryker Corporation (1SYK) FAQ

What is the stock price today?

The current price is €242.30.

On which exchange is it traded?

Stryker Corporation is listed on XMIL.

What is its stock symbol?

The ticker symbol is 1SYK.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.15%.

What is its market cap?

As of today, the market cap is 121.11B.

Has Stryker Corporation ever had a stock split?

Stryker Corporation had 9 splits and the recent split was on May 17, 2004.

Stryker Corporation Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Kevin A. Lobo CEO
XMIL Exchange
US8636671013 ISIN
US Country
56,000 Employees
30 Sep 2026 Last Dividend
17 May 2004 Last Split
- IPO Date

Overview

Stryker Corporation is a leading medical technology company with a primary focus on providing innovative solutions in the medical field. The company operates through two main segments: MedSurg and Neurotechnology, and Orthopaedics and Spine. These segments cater to a wide array of medical needs, from total joint replacements and trauma surgeries to advanced neurosurgical and neurovascular solutions. Founded in 1941 and based in Portage, Michigan, Stryker has grown into a global entity, distributing its products in approximately 75 countries. The company's commitment to enhancing patient and caregiver outcomes is evident through its extensive product portfolio, advanced medical devices, and a strategic approach to market distribution and customer engagement.

Products and Services

Stryker Corporation offers a diverse range of products and services designed to cater to various facets of medical care, spanning various specialties and requirements. These include:

  • Orthopaedics and Spine: This involves providing implants used in total joint replacements for hip, knee, and shoulder surgeries, along with trauma and extremities surgeries. The segment is also known for its spinal implant products, which consist of systems for cervical and thoracolumbar applications, including fixation, minimally invasive, and interbody systems targeted at spinal injury, complex spine, and degenerative therapies.
  • MedSurg and Neurotechnology: A broad range of surgical equipment and surgical navigation systems fall under this segment, alongside endoscopic and communications systems. Stryker also offers products aimed at enhancing patient handling, emergency medical care, and intensive care through disposable products, reprocessed and remanufactured medical devices. Additionally, clinical communication and workflow solutions, along with a variety of medical device products for different specialties, are provided, focusing on patient and caregiver safety technologies.
  • Neurosurgical, Neurovascular, and Craniomaxillofacial Implant Products: This category includes products for minimally invasive endovascular procedures, brain and open skull-based surgical procedures, and biosurgery products like synthetic bone grafts and vertebral augmentation products. For the treatment of acute ischemic and hemorrhagic stroke, minimally invasive products are offered. The segment also covers craniomaxillofacial implant products, including devices for cranial, maxillofacial, and chest wall surgeries, as well as dural substitutes and sealants.

These products are made available to doctors, hospitals, and other healthcare facilities through a blend of company-owned subsidiaries and branches, supplemented by a network of third-party dealers and distributors worldwide.

Contact Information

Address: 1941 Stryker Way
Phone: 269 385 2600